Home > Balance Sheet > BETA DRUGS

BETA DRUGS
Net Current Assets

    Back to Balance Sheet
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Net Current Assets History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Current Assets (Including Current Investments) ₹228 Cr₹93 Cr₹65 Cr₹48 Cr₹35 Cr

What is the latest Net Current Assets ratio of BETA DRUGS ?

The latest Net Current Assets ratio of BETA DRUGS is ₹228 Cr based on Mar2025 Consolidated results.
Year Net Current Assets
Mar2025₹228 Cr
Mar2024₹93 Cr
Mar2023₹65 Cr
Mar2022₹48 Cr
Mar2021₹35 Cr

How is Net Current Assets of BETA DRUGS Trending?

Years Net Current Assets % Change
Mar2025 ₹228 Cr
145.01
Mar2024 ₹93 Cr
44.12
Mar2023 ₹65 Cr
34.76
Mar2022 ₹48 Cr
38.13
Mar2021 ₹35 Cr -

Compare Net Current Assets of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,831.3 Cr 1.9% 12.8% 50.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,848.0 Cr -1.4% -1.3% 21.5% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr 2.7% 16.1% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,109.0 Cr -1.5% -3.3% 35.6% Stock Analytics
CIPLA ₹117,139.0 Cr -0.7% 1.4% -2% Stock Analytics
DR REDDYS LABORATORIES ₹100,328.0 Cr 3.9% -1.8% 0.4% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

1.9%

12.8%

50.1%

SENSEX

-0.6%

1.1%

-3.2%


You may also like the below Video Courses